New York DOH to renew Narcan contract but consider other options moving forward
ALBANY, N.Y. -- Following recent pressure from addiction services organizations, the New York state Department of Health appears to be open to purchasing other brands of opioid overdose reversal drug naloxone besides the most well-known, Narcan.
However, that likely won't happen until at least next year. The DOH confirmed Thursday it will opt in to another year of the current $21 million contract with pharmaceutical subsidiary Emergent Devices.